Evaluating retinal health in patients with cerebral small vessel disease
Official title: Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease
Run by Zhejiang Provincial People's Hospital · NCT06431711 · Data updated 2026-11-12
This study is testing if a special eye scan can help doctors understand how brain health is affected in older adults with cerebral small vessel disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 35 Years and up |
| Sex | All |
| Enrollment | 2400 (estimated) |
| Sponsor | Zhejiang Provincial People's Hospital Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | March 31, 2029 |
| Study ends | March 31, 2034 |
| Registry record updated | May 29, 2024 |
| Trial ID | NCT06431711 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 35 years old who have undergone multimodal MRI and have any imaging markers indicative of cerebral small vessel disease.
✕Probably not a fit
Patients with known diseases that may worsen CSVD or those with significant eye diseases that could affect fundus assessment are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with cerebral small vessel disease (CSVD), a condition that significantly affects older adults and is linked to stroke and dementia. It utilizes optical coherence tomography angiography (OCTA), a non-invasive imaging technology, to assess retinal and choroidal health and its correlation with CSVD markers. The study aims to explore the relationship between OCTA-derived parameters and CSVD, providing insights into the potential clinical value of these measurements for screening and monitoring patients. By analyzing these parameters, the research seeks to enhance understanding of CSVD and its implications for brain health.
Why it matters
Potential benefit: If successful, this study could improve early detection and management of cerebral small vessel disease, potentially reducing the risk of stroke and dementia in affected patients.
How similar studies have gone: While the use of OCTA in assessing retinal health is emerging, this specific approach to correlate OCTA parameters with CSVD markers is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Older than 35 years old; 2. Patients who underwent Multimodal MRI with any CSVD imaging marker; 3. Subjects who have signed informed consent. Exclusion Criteria: 1. Patient who was unable to cooperate with examinations; 2. There are known diseases that may cause or worsen CSVD (brain injury, Down syndrome, Alzheimer's disease, Parkinson's disease, etc.); 3. There are known eye diseases or severe underlying fundus lesions that may impact fundus assessment; 4. Suffering from serious systemic diseases, such as heart, liver, kidney diseases or major mental illnesses; 5. Contraindications for imaging examinations Exit Criteria: 1. Not meet the inclusion criteria. 2. For any poor adherence, not comply with the requirements of the follow-up, or safety reasons determined by investigator. 3. Any adverse or serious adverse events during the study period judged by investigator
Where it's running
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Sheng Zhang
- Email: zhangsheng@hmc.edu.cn
- Phone: +8618758188313
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Choroid and retina imaging in angle‑closure versus open‑angle glaucoma using OCT and OCTA
This project will use OCT and OCTA eye scans to see if choroidal and retinal features differ between people with primary angle‑closure disease, primary open‑angle glaucoma, and healthy volunteers.
-
Can QSM MRI help tell MS from age-related brain changes in older adults
This study tests whether an advanced MRI technique called QSM can better differentiate MS-related brain lesions from age-related or small vessel changes in people aged 50–70.
-
Same-day ambulatory stroke unit care for older adults with minor stroke or TIA
This trial will try whether same-day ambulatory stroke unit care works as well as inpatient stroke unit care for people aged 60 and older with minor ischemic stroke, transient ischemic attack, or retinal ischemia.
-
How a quick sugar dose affects choroidal thickness
We will see if taking 30 grams of glucose changes the thickness of the macular choroid in adults without diabetes who have less than 6 diopters of refractive error.
-
Registry for people with cerebral small vessel disease.
This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.
-
Observing brain blood vessel health in a community
This study looks at how blood vessel health in the brain is affected by conditions like high blood pressure and diabetes in adults aged 50-75 living in Beijing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.